Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the analysis found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results